Professor Helal: A Decade of Professional Advancement through ISN Initiatives Prof. Helal’s professional journey is one of many to be showcased on the ISN@Work Gallery launching at WCN’21. This gallery will highlight several ISN members whose work and professional development have benefited from ISN granting programs, as well as those who tirelessly advocate to raise awareness...
Why do some patients receiving hemodialysis remain cheerful, hopeful, outward-looking, and enjoy a rich life, while others suffer debilitating depression and other emotional problems? Can whatever makes some patients more resilient be “bottled” and given to those less resilient to help them? These are the questions that Chris McIntyre, professor of medicine, medical biophysics, and...
Around 10% of the world’s population is thought to be affected by chronic kidney disease (CKD). Professor Sophie de Seigneux believes that understanding how patients with acute kidney injury (AKI) go on to develop CKD could be a vital step in reducing this burden. She says: “There are currently very few treatments that are able...
Hemodialysis is life-sustaining therapy for many patients with chronic kidney disease, but choosing how to access a patient’s blood for treatment presents pros and cons, depending on their situation. “We have seen that a ‘one-size-fits-all’ approach to medicine, and for hemodialysis vascular access, does not necessarily work for all,” says Charmaine Lok, Professor of Medicine...
It is well-established that African Americans are more than three times as likely to develop end-stage renal disease (ESRD) than non-Hispanic white Americans. Research also shows that Black people living in sub-Saharan Africa have a similarly high predisposition to developing chronic kidney disease (CKD). “This increased risk of CKD is attributable in part to variants...
Most research into kidney health, disease, its progression, and treatment has been based on the male model and does not take into account the impact of sex and gender, according to Professor Sofia Ahmed. In her plenary, keynote presentation at WCN’21, Prof. Ahmed, from the Cumming School of Medicine at the University of Calgary, Canada,...
The Partnership for Health System Sustainability Resilience (PHSSR), founded by the World Economic Forum (WEF), the London School of Economics, and AstraZeneca, is holding a summit from March 15-19 2021. Registration details to follow shortly. “Improving the effectiveness of care” will bring together academia and the public and private sectors to share insights from nine months...
Help expand trial participation within the nephrology community: Join colleagues online for a lively exchange of ideas on February 16 at 9 p.m. ET. #NephTrials The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering on the #NephTrials initiative to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials. The #NephTrials initiative is an exciting new series...
Throughout 2021, the ISN will present a series of interviews with our Collective-Member Societies. For this edition, we interviewed Rudolf P. Wüthrich, President of the Swiss Society of Nephrology. This society has been an ISN Collective-Member for over a decade. In 2019, the ISN launched a new partnership with the Swiss Society of Nephrology and the...
Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlights: Daily, weekly, or monthly cholecalciferol dosing regimens are similarly effective in children with CKD View the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN...
The ISN Clinical Research Program supports research and education programs in low-to-middle income countries that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease. The deadline for online submission of proposals is May 1, 2021. Proposals are reviewed by an ISN for approval before they are submitted online. To...
The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials, especially in terms of different trial designs. The ISN-ACT produces the Global Trials Focus, a monthly list that identifies and summarizes recent interesting trials relevant...
This year, the ISN Community Film Event is running in collaboration with the 2021 World Kidney Day (WKD) Campaign, “Living Well with Kidney Disease.” In addition to the ISN Community Film Award for 2021, a “WKD 2021 Best Film” award will go to the film that gets the most votes on World Kidney Day. All...
The ISN has partnered with several leading organizations to deliver expert knowledge in specialty subjects at WCN’21, including: KDIGO and the ISN’s joint session, the KDIGO Conference on Dialysis: Getting the Basics Right, will provide insights for improving clinical practices on dialysis for all nephrologists despite variation varying global practices. The session will be held...
The ISN was deeply saddened to learn of the death of Robert William Schrier, a giant of global nephrology and modern medicine. Alongside his many achievements in academic nephrology, Bob Schrier committed himself to the ISN and became one of its most effective and innovative leaders. He served in ISN leadership for more than twenty...
Meet the moderator and keynote speakers Moderator Speaker Speaker Richard Horton Editor-in-Chief, The Lancet Dr Soumya Swaminathan Chief Scientist at WHO Sir George Alleyne Director Emeritus, Pan American Health Organization (PAHO) The 3rd ISN Global Kidney Policy Forum (GKPF) at Virtual WCN’21 will build on the work started in Mexico City in 2017 and continued in Melbourne in 2019 by bringing together key decision-makers and...
Kidney International has published many exciting research papers by Early Career Researchers across the globe in the last 2 years. We would like to recognize the exceptional quality of their research and their contribution to advancing kidney health by calling for nominations from our membership for the best original research papers published in Kidney International in 2019 and 2020....
BRIDGING THE GAPS: ISN ADVOCACY TACKLES THE GLOBAL BURDEN OF KIDNEY DISEASE Welcome, members and allies, to the inaugural edition of Bridging the Gaps, the ISN’s quarterly update on how we’re advocating and collaborating with partners to tackle the global burden of kidney disease. As you know, about 850 million people worldwide have some sort of...
Astellas has produced three videos on anaemia of CKD. As part of its commitment to building capacity in healthcare professionals, the ISN is currently hosting the open-access content on the ISN Academy: ‘Expert insight: Anaemia of CKD’ - Sunil Bhandari, a consultant in general medicine and nephrology, presents insights on the burden of anaemia of CKD and...
In recognition of Early Career Researchers, the ISN and Kidney International (KI) are calling for nominations toward selecting four best original research papers (two each in basic and clinical science) published in KI in 2019 and 2020. The nomination period opens on January 21, 2021. Papers will be assessed on the novelty of research, robustness, and...
